Xeris Biopharma Holdings, Inc. Files Form 8-K with SEC (June 29, 2026)

This is a Form 8-K filing with the SEC by Xeris Biopharma Holdings, Inc., dated June 29, 2026. The document is a regulatory filing reporting a current event (likely a material corporate event) as required by securities law. The content is a standard SEC form with corporate identification details including the company's name, state of incorporation (Delaware), commission file number, IRS employer identification number, and principal executive offices address in Chicago, Illinois.